# Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome

> **NCT04045171** · — · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 200 (estimated)

## Conditions studied

- Nephrotic Syndrome
- Tacrolimus
- Pharmacokinetics

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT04045171
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-10
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-08-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04045171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04045171, "Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04045171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*